Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · IEX Real-Time Price · USD
1.890
+0.050 (2.72%)
Jul 22, 2024, 10:55 AM EDT - Market open
Cognition Therapeutics Employees
As of December 31, 2023, Cognition Therapeutics had 28 total employees, including 25 full-time and 3 part-time employees. The number of employees increased by 3 or 12.00% compared to the previous year.
Employees
28
Change (1Y)
3
Growth (1Y)
12.00%
Revenue / Employee
n/a
Profits / Employee
-$1,027,393
Market Cap
74.91M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28 | 3 | 12.00% |
Dec 31, 2022 | 25 | 4 | 19.05% |
Dec 31, 2021 | 21 | 1 | 5.00% |
Dec 31, 2020 | 20 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Eagle Pharmaceuticals | 134 |
Theratechnologies | 103 |
MSP Recovery | 88 |
Kronos Bio | 63 |
Spero Therapeutics | 46 |
Ovid Therapeutics | 40 |
enVVeno Medical | 31 |
Genelux | 23 |
CGTX News
- 20 days ago - Results from Cognition Therapeutics' Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease Accepted for Presentation at AAIC - GlobeNewsWire
- 2 months ago - Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease - GlobeNewsWire
- 2 months ago - Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update - GlobeNewsWire
- 3 months ago - Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies - GlobeNewsWire
- 3 months ago - Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease - GlobeNewsWire
- 3 months ago - Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 months ago - Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 - GlobeNewsWire
- 4 months ago - Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update - GlobeNewsWire